Method for preparing anidulafungin

A technology of anidulungin and protecting group, applied in the field of preparation of echinocandin antifungal drugs, achieving high yield and convenient post-treatment

Inactive Publication Date: 2013-06-12
HYBIO PHARMA
View PDF3 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The disadvantage of this method is that it relies on echinocandin antibiotics as the raw material basis and needs the support of microbial culture technology
So far, there is no report on the total synthesis of micafungin

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for preparing anidulafungin
  • Method for preparing anidulafungin
  • Method for preparing anidulafungin

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0042] Embodiment 1: Synthesis of Fmoc-P-OH unnatural amino acid:

[0043] (1) Synthesis of ortho-dihydroxyl groups by Sharpless asymmetric dihydroxylation reaction. 70g (217mmol) K 3 Fe(CN) 6 , 29.3g (217mmol) K 2 CO 3 , 53.2 mg (0.14 mmol) K 2 OSo 2 (OH) 4 And 0.56g (0.7mmol) hydroquinidine 1,4-(2,3-naphthyridine) diether ((DHQD) 2 -PHAL) was dissolved in 350ml tert-butanol and 350ml water, and stirred at room temperature for 10 minutes. Add 6.7g (70mmol) ammonium methanesulfonate, and at 0°C, Boc-4-ene-L-ornithine lactam (JournalofOrganometallicChemistry691 (2006), 5487-5496, experimental part 4.3) prepared according to the method of known literature .3, Compound 24) 14.9g (70mmol) was added to the system, and kept at 0°C for 40h. Subsequently, 105 g (833 mmol) of sodium sulfite was added, the reaction was naturally raised to room temperature and stirred for 1 hour, and 700 ml of ethyl acetate was added. The aqueous layer was extracted with ethyl acetate (3 x 200m...

Embodiment 2

[0046] Embodiment 2: the synthesis of Fmoc-P-CTC resin

[0047] Weigh 20.0 g of 2-CTC resin with a substitution degree of 0.7 mmol / g, add it to a solid-phase reaction column, and wash it twice with DMF. After swelling the resin with DMF for 30 minutes, take 24.0g of Fmoc-P-OH and dissolve it in DMF, add 14.6mL of DIPEA in an ice-water bath to activate for 3 minutes, then add it to the above-mentioned reaction column filled with resin, react for 2 hours, add 20mL of anhydrous Methanol blocked for 1 hour. Wash 3 times with DMF and 3 times with DCM, seal with anhydrous methanol for 30 minutes, shrink and dry with methanol to obtain Fmoc-P-CTC resin, the detection degree of substitution is 0.56mmol / g.

Embodiment 3

[0048] Example 3: Synthesis of (4S)-N-Fmoc-4-acetoxy-4-(4'-acetoxy)phenyl-L-threonine:

[0049] Dissolve 50g (185mmol) of p-benzyloxybenzaldehyde in 250ml of freshly distilled DCM, add 101.4g (185mmol) of phosphine ylide, and stir at room temperature for 4 hours. The reaction solution is purified by silica gel flash column chromatography to obtain 80.1g of white solid. Dissolve this solid in 300ml of freshly distilled DCM, add a solution of 15g (277mmol) sodium methoxide in 2300ml of anhydrous methanol, stir and react at room temperature for 30 minutes, add 1500ml of 1mol / L hydrochloric acid solution to acidify, spin off the organic solvent, and use the remaining liquid DCM extraction (3 x 600ml). The organic phases were combined, washed twice with saturated brine, dried over anhydrous sodium sulfate for 2 h, and then concentrated under reduced pressure to remove the solvent. The residue and 152.3g (302mmol) 2,3,4-triacetyl-D-methylglucopyranosyl-(N-phenyl)-2,2,2-trifluoroace...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a solid phase-liquid phase full synthetic method for preparing anidulafungin. The method comprises that Fmoc-P-resin serves as a carrier, a solid phase polypeptide synthetic method is adopted to gradually couple amino acid with an Fmoc protecting group from the C end to the N end, and then the protecting group is deprived through splitting, intramolecular reaction and liquid phase condensation to obtain the anidulafungin. The method is high in yield, brings convenience to aftertreatment and provides a new thinking way for industrial scale production of the anidulafungin.

Description

technical field [0001] The invention relates to a method for preparing echinocandin antifungal drugs, in particular to a method for preparing anidungin. Background technique [0002] Echinocandins are new semi-synthetic antifungal drugs, which inhibit the synthesis of fungal cell walls by inhibiting the activity of β-1,3-glucan synthase, and have low toxicity and good kinetic properties. Anidulafungin (Anidulafungin), the third-generation echinocandin antifungal drug, with the trade name Eraxis, was launched in the United States in December 2006 and is used for the following fungal infections: 1) Candidemia and other types of Candida infections (abdominal abscess, peritonitis); 2) esophageal candida. [0003] The structure of Anifungin is shown below: [0004] [0005] At present, Anifungin is mainly prepared by a semi-synthetic method: the acyl group of the exocyclic amide in the echinocandin antibiotic structure is removed by an enzyme reaction, and then the side chai...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07K7/56C07K1/06C07K1/04C07K1/02
CPCY02P20/55
Inventor 韦畅勇刘建马亚平袁建成
Owner HYBIO PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap